<unk>  is a mucocutaneous epithelial human growth factor that is FDA approved for the treatment of severe oral mucositis in patients with hematologic malignancies receiving myelotoxic therapy requiring hematopoietic stem cell support.   Common adverse reactions include rash, fever, elevated serum amylase (Grade 3/4), pruritus, erythema, and edema.
Palifermin
Undecylenic acid
Mecasermin
Trichlorfon
Gedocarnil
Dimethylcarbate
Bitolterol
Ferruginol